Small Cell Neuroendocrine Carcinoma — Research

Small Cell Neuroendocrine Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-12	17,777	`("Carcinoma, Small Cell"[mh] OR "Carcinoma, Oat Cell"[mh])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	436	`("Carcinoma, Small Cell"[mh] OR "Carcinoma, Oat Cell"[mh]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	64	`("Carcinoma, Small Cell"[mh] OR "Carcinoma, Oat Cell"[mh]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (9)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–9 of 9 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Clinical correlation of extensive-stage small-cell lung cancer genomics.
· Ann Oncol · 2016 · PMID 26802149 · validated civic_curation pubmed
Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer.
· Lung Cancer · 2015 · PMID 25601188 · validated civic_curation pubmed
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.
· Cancer Discov · 2014 · PMID 24934408 · validated civic_curation pubmed
CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.